Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. [electronic resource]
Producer: 20100105Description: 575-81 p. digitalISSN:- 1878-1705
- Animals
- Cell Proliferation -- drug effects
- Curcuma
- Curcumin -- therapeutic use
- Disease Progression
- Dose-Response Relationship, Drug
- Down-Regulation
- Encephalomyelitis, Autoimmune, Experimental -- drug therapy
- Female
- Freund's Adjuvant
- Guinea Pigs
- Humans
- Immunization
- Interleukin-17 -- genetics
- Interleukin-6 -- genetics
- Interleukins -- genetics
- Jurkat Cells
- Multiple Sclerosis -- immunology
- Myelin Basic Protein -- administration & dosage
- Nuclear Receptor Subfamily 1, Group F, Member 3 -- genetics
- Peptides -- administration & dosage
- Phosphorylation
- Phytotherapy
- Rats
- Rats, Inbred Lew
- Rhizome
- STAT3 Transcription Factor -- genetics
- Spinal Cord -- pathology
- T-Lymphocytes, Helper-Inducer -- drug effects
- Transforming Growth Factor beta -- genetics
- Interleukin-21
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.